343 related articles for article (PubMed ID: 21549350)
1. Bioactivity and cellular structure of Candida albicans and Candida glabrata biofilms grown in the presence of fluconazole.
Gomes PN; da Silva WJ; Pousa CC; Narvaes EA; Del Bel Cury AA
Arch Oral Biol; 2011 Nov; 56(11):1274-81. PubMed ID: 21549350
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Candida biofilms to histatin 5 and fluconazole.
Konopka K; Dorocka-Bobkowska B; Gebremedhin S; Düzgüneş N
Antonie Van Leeuwenhoek; 2010 May; 97(4):413-7. PubMed ID: 20140514
[TBL] [Abstract][Full Text] [Related]
3. Environmental pH influences Candida albicans biofilms regarding its structure, virulence and susceptibility to fluconazole.
de Vasconcellos AA; Gonçalves LM; Del Bel Cury AA; da Silva WJ
Microb Pathog; 2014; 69-70():39-44. PubMed ID: 24685701
[TBL] [Abstract][Full Text] [Related]
4. The effect of Streptococcus mutans and Candida glabrata on Candida albicans biofilms formed on different surfaces.
Pereira-Cenci T; Deng DM; Kraneveld EA; Manders EM; Del Bel Cury AA; Ten Cate JM; Crielaard W
Arch Oral Biol; 2008 Aug; 53(8):755-64. PubMed ID: 18395698
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of Caspofungin combined with Fluconazole on mixed Candida albicans and Candida glabrata biofilm.
Pesee S; Angkananuwat C; Tancharoensukjit S; Muanmai S; Sirivan P; Bubphawas M; Tanarerkchai N
Med Mycol; 2016 May; 54(4):384-93. PubMed ID: 26768371
[TBL] [Abstract][Full Text] [Related]
6. Salivary pellicles equalise surfaces' charges and modulate the virulence of Candida albicans biofilm.
Cavalcanti YW; Wilson M; Lewis M; Williams D; Senna PM; Del-Bel-Cury AA; da Silva WJ
Arch Oral Biol; 2016 Jun; 66():129-40. PubMed ID: 26945171
[TBL] [Abstract][Full Text] [Related]
7. Silver colloidal nanoparticles: antifungal effect against adhered cells and biofilms of Candida albicans and Candida glabrata.
Monteiro DR; Gorup LF; Silva S; Negri M; de Camargo ER; Oliveira R; Barbosa DB; Henriques M
Biofouling; 2011 Aug; 27(7):711-9. PubMed ID: 21756192
[TBL] [Abstract][Full Text] [Related]
8. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata.
Dovigo LN; Pavarina AC; Mima EG; Giampaolo ET; Vergani CE; Bagnato VS
Mycoses; 2011 Mar; 54(2):123-30. PubMed ID: 19889173
[TBL] [Abstract][Full Text] [Related]
9. The effect of silver nanoparticles and nystatin on mixed biofilms of Candida glabrata and Candida albicans on acrylic.
Silva S; Pires P; Monteiro DR; Negri M; Gorup LF; Camargo ER; Barbosa DB; Oliveira R; Williams DW; Henriques M; Azeredo J
Med Mycol; 2013 Feb; 51(2):178-84. PubMed ID: 22803822
[TBL] [Abstract][Full Text] [Related]
10. The expression of genes involved in the ergosterol biosynthesis pathway in Candida albicans and Candida dubliniensis biofilms exposed to fluconazole.
Borecká-Melkusová S; Moran GP; Sullivan DJ; Kucharíková S; Chorvát D; Bujdáková H
Mycoses; 2009 Mar; 52(2):118-28. PubMed ID: 18627475
[TBL] [Abstract][Full Text] [Related]
11. Architectural analysis, viability assessment and growth kinetics of Candida albicans and Candida glabrata biofilms.
Seneviratne CJ; Silva WJ; Jin LJ; Samaranayake YH; Samaranayake LP
Arch Oral Biol; 2009 Nov; 54(11):1052-60. PubMed ID: 19712926
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study.
Lamfon H; Porter SR; McCullough M; Pratten J
J Antimicrob Chemother; 2004 Feb; 53(2):383-5. PubMed ID: 14729749
[TBL] [Abstract][Full Text] [Related]
13. Influence of substratum position and acquired pellicle on Candida albicans biofilm.
Cavalcanti IM; Silva WJ; Lucena SC; Pousa CC; Del Bel Cury AA
Braz Oral Res; 2013; 27(4):369-75. PubMed ID: 23780496
[TBL] [Abstract][Full Text] [Related]
14. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
15. Exopolysaccharide matrix of developed Candida albicans biofilms after exposure to antifungal agents.
da Silva WJ; Gonçalves LM; Seneviratne J; Parahitiyawa N; Samaranayake LP; Del Bel Cury AA
Braz Dent J; 2012; 23(6):716-22. PubMed ID: 23338267
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
17. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
18. In vivo Candida glabrata biofilm development on foreign bodies in a rat subcutaneous model.
Kucharíková S; Neirinck B; Sharma N; Vleugels J; Lagrou K; Van Dijck P
J Antimicrob Chemother; 2015 Mar; 70(3):846-56. PubMed ID: 25406296
[TBL] [Abstract][Full Text] [Related]
19. Detailed comparison of Candida albicans and Candida glabrata biofilms under different conditions and their susceptibility to caspofungin and anidulafungin.
Kucharíková S; Tournu H; Lagrou K; Van Dijck P; Bujdáková H
J Med Microbiol; 2011 Sep; 60(Pt 9):1261-1269. PubMed ID: 21566087
[TBL] [Abstract][Full Text] [Related]
20. Fluconazole impacts the extracellular matrix of fluconazole-susceptible and -resistant
Panariello BHD; Klein MI; Mima EGO; Pavarina AC
J Oral Microbiol; 2018; 10(1):1476644. PubMed ID: 29887974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
